Mustafin, R.N.,
Bermisheva, M.A.,
Karunas, A.S.,
Akhmetshin, A.A.,
Monakhova, A.S.,
Khusnutdinova, E.K. (2025) of Bashkortostan, sequencing the NF1
gene in their DNA samples as well as whole genome sequencing using the WGS
mutations in NF1
gene. Protein product of NF1 is a neurofibromin, which inhibits RAS-RAF-MEK-ERK system
РОЛЬ НАСЛЕДСТВЕННЫХ ФАКТОРОВ В ПАТОГЕНЕЗЕ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫПушкарев, А.В.,
Меньшиков, К.В.,
Пушкарев, В.А.,
Султанбаев, А.В.,
Галеев, М.Г.,
Pushkarev, A.V.,
Menshikov, K.V.,
Pushkarev, V.A.,
Sultanbaev, A.V.,
Galeev, M.G. (2020) патологий,
встречается в 15-20% от всех случаев РМЖ и в основном опосредован мутациями в генах BRCA 1/
2. У
Shnayder, Natalia A.,
Ashhotov, Azamat V.,
Trefilova, Vera V.,
Novitsky, Maxim A.,
Medvedev, German V.,
Petrova, Marina M.,
Narodova, Ekaterina A.,
Kaskaeva, Daria S.,
Chumakova, Galina A.,
Garganeeva, Natalia P.,
Lareva, Natalia V.,
Al-Zamil, Mustafa,
Asadullin, Azat R.,
Nasyrova, Regina F. (2023) engineering); genetic technologies (
gene modifications, microRNA, and molecular inducers of IDD); technologies
RNAs influence various cellular processes, such as
gene expression, vascular tone, and inflammation, making them
вариантами генов AKAP13, ATP11A, DPP9, DSP, IVD, IL1RN, FAM13A, MUC5B, SFTPC, SPPL
2C, TERC, TERT, TOLLIP